24
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Topical quinolone nadifloxacin (OPC-7251) in bacterial skin disease: clinical evaluation in a multicenter open trial and in vitro antimicrobiological susceptibility testing

, &
Pages 87-92 | Received 10 May 1996, Accepted 18 Dec 1996, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pietro Nenoff. (2006) Acne vulgaris and bacterial skin infections: review of the topical quinolone nadifloxacin. Expert Review of Dermatology 1:5, pages 643-654.
Read now
Michael R Jacobs & Peter C Appelbaum. (2006) Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771. Expert Opinion on Pharmacotherapy 7:14, pages 1957-1966.
Read now

Articles from other publishers (4)

Rashmi Sarkar, Sushil Tahiliani, Amit Madan, Anil Abraham, Anil Ganjoo, Bela J. Shah, Kiran Godse, Koushik Lahiri, T. Salim, Archana KaradkheleSnehal MuchchalaRahul Rathod. (2021) Role of topical nadifloxacin as an empirical treatment in patients with skin and soft-tissue infections in India: A review and consensus. Cosmoderma 1, pages 61.
Crossref
P. Nenoff, D. Koch, C. Krüger, C. Neumeister, M.R. Götz, U. Schwantes, R.‐H. Bödeker & C. Borelli. (2021) Activity of nadifloxacin and three other antimicrobial agents against Cutibacterium acnes isolated from patients with acne vulgaris . Journal of the European Academy of Dermatology and Venereology 35:10.
Crossref
G. Vannuruswamy, G. V. N. Rathna, B. S. T. Gadgil & A. P. Gadad. (2015) Blends of shellac as nanofiber formulations for wound healing. Journal of Bioactive and Compatible Polymers 30:5, pages 472-489.
Crossref
Varsha Narayanan, Salman Motlekar, Ganesh Kadhe & Seema Bhagat. (2014) Efficacy and Safety of Nadifloxacin for Bacterial Skin Infections: Results from Clinical and Post-Marketing Studies. Dermatology and Therapy 4:2, pages 233-248.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.